Skip to research
Margin Monkey THEMARGINMONKEY Start my free trialTry free

Tactile Systems Technology (TCMD) stock in plain English

Free brief · no signupStart here
TCMDPublished Nov 14, 2026
Tactile Systems Technology Inc
Healthcare · Medical Devices
Manufactures wearable pneumatic compression therapy systems for patients managing lymphedema and respiratory conditions.
Assets:
Minneapolis headquartersRuns primary corporate and assembly operations in Minnesota
Flexitouch systemFlagship advanced pneumatic compression line for lymphedema
AffloVest linePortable high frequency chest wall oscillation garment line
Locked assetIn the full report
Rated Nov 19, 2026

Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.

80
OPS ScoreOperating finances
Latest quote
-1.63%$25.99
$582.21M
25.2×
$357.18M

Change shown by the quote provider. Data may be delayed.

Financial statements, in plain wordsSales, profit, debt and cash, year by year
Published Nov 14, 2026Quotes updated Nov 20, 04:05 UTCOPS Score, TMM Score and the rating are research summaries, not advice or forecasts.
That was TCMD. The desk has 1,900+ more companies.Each one comes with its scores, its flags and the sources behind them.
7 days free · No card

What does Tactile Systems Technology (TCMD) do?

Tactile Systems Technology Inc (TCMD) is a U.S.-listed company in Healthcare (Medical Devices). What it does: Manufactures wearable pneumatic compression therapy systems for patients managing lymphedema and respiratory conditions. It delivers pneumatic compression devices directly to patients for chronic swelling and lung disease management at home. It is worth $582.21M on the market and sold $357.18M over the last year.

Market cap
$582.21M
P/E ratio
25.2×
Annual sales
$357.18M
Sector
Healthcare
Industry
Medical Devices
Brief updated
Nov 14, 2026

Brands and businesses behind TCMD

  • Flexitouch: An advanced pneumatic compression system that stimulates lymphatic drainage, earning revenue through prescription sales paid by health insurers.
  • AffloVest: A portable airway clearance vest that loosens lung secretions, earning revenue from prescription sales to patients with respiratory illnesses.
  • Entre: A basic pneumatic compression device that manages swelling, generating revenue through direct insurance reimbursements for entry level patient care.

TCMD’s flags, in plain English

Each flag is a number from Tactile Systems Technology’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 14, 2026.

Low debt

Low debt, only 8% of shareholder equity. The company owes very little compared with what it earns, so a bad year is less likely to force its hand.

Wide Gross Margin

Gross margin of 76.3% after the cost of making its products. There is a large gap between what its products cost to make and what they sell for, and that gap pays for everything else.

Growth vs Price

The price looks reasonable for how fast it is growing. The price looks reasonable for how fast its profits are growing.

Heavily Shorted

12.9% of tradable shares are bet against (sold short). A large share of the stock has been borrowed and sold by traders betting it will fall. That can be a warning, and it can also push the price up fast if they rush to buy it back.

2 more green flags and 1 more risk note open with the free trial. Try it free for 7 days.

Questions about TCMD

How big is Tactile Systems Technology?

Tactile Systems Technology’s market cap is $582.21M: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $357.18M: what customers paid the company over the last year, before any costs.

What is TCMD’s P/E ratio?

TCMD’s P/E ratio is 25.2×. Investors pay about 25.2 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.

What could go wrong with TCMD?

The business relies heavily on Medicare and private commercial insurers agreeing to reimburse the full cost of its therapies. That is one risk on Tactile Systems Technology’s card. Its first risk flag is Heavily Shorted, explained above. The card holds 1 more risk note for trial accounts. A flag reads what the company reported. It does not predict the price.

Where do these numbers come from?

From Tactile Systems Technology’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. TCMD’s filings on SEC.gov. The Margin Monkey is research, not advice.

Your first 7 days are free.Search all 1,900+ companies and open every card. Members also get the ratings, Picks and the TMM Score.
7 days free · No card